Trials / Recruiting
RecruitingNCT06752122
Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.
Safety, Tolerability and Pharmacokinetics of Single-ascending Doses of RCS-21 in Healthy Volunteers. A Double Blind, Randomized, Placebo Controlled Phase I Study.
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- RNATICS GmbH · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to evaluate the safety and tolerability of RCS-21 in healthy volunteers. Participants will be asked to inhale a single dose of RCS-21 and their health status will be constantly monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo (SAD) | Inhalation of a single dose. |
| DRUG | RCS-21 (SAD) | Inhalation of a single dose. |
Timeline
- Start date
- 2025-02-18
- Primary completion
- 2026-06-01
- Completion
- 2026-08-01
- First posted
- 2024-12-30
- Last updated
- 2025-11-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06752122. Inclusion in this directory is not an endorsement.